Relevant bibliographies by topics / Interleukin 10 / Journal articles

Journal articles on the topic 'Interleukin 10'

To see the other types of publications on this topic, follow the link: Interleukin 10.
Author: Grafiati
Published: 4 June 2021
Last updated: 11 March 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Interleukin 10.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

&NA;. "Interleukin-10." Drugs in R & D 1, no. 3 (January 1999): 262–64. http://dx.doi.org/10.2165/00126839-199901030-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Asadullah, K., R. Sabat, M. Friedrich, W. Docke, H. Volk, and W. Sterry. "Interleukin-10." Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 5, no. 3 (August 1, 2006): 223–31. http://dx.doi.org/10.2174/187152306778017700.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Parsons, Polly E. "Interleukin-10." Critical Care Medicine 26, no. 5 (May 1998): 818–19. http://dx.doi.org/10.1097/00003246-199805000-00007.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Goldman, Michel, Thierry Velu, and Marina Pretolani. "Interleukin-10." BioDrugs 7, no. 1 (January 1997): 6–14. http://dx.doi.org/10.2165/00063030-199707010-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Moore, K. W., A. O'Garra, R. W. Malefyt, P. Vieira, and T. R. Mosmann. "Interleukin-10." Annual Review of Immunology 11, no. 1 (April 1993): 165–90. http://dx.doi.org/10.1146/annurev.iy.11.040193.001121.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Umetsu, Dale T., and Rosemarie H. DeKruyff. "Interleukin-10." American Journal of Respiratory Cell and Molecular Biology 21, no. 5 (November 1999): 562–63. http://dx.doi.org/10.1165/ajrcmb.21.5.f171.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Zlotnik, Albert, and Kevin W. Moore. "Interleukin 10." Cytokine 3, no. 5 (September 1991): 366–71. http://dx.doi.org/10.1016/1043-4666(91)90039-g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Klava, Andrew. "Interleukin-10." Archives of Surgery 132, no. 4 (April 1, 1997): 425. http://dx.doi.org/10.1001/archsurg.1997.01430280099016.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

DEWAALMALEFYT, R., M. RONCAROLO, H. SPITS, and J. DEVRIES. "Interleukin-10." Current Opinion in Immunology 4, no. 3 (June 1992): 314–20. http://dx.doi.org/10.1016/0952-7915(92)90082-p.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reineke, Ulrich, Robert Sabat, Hans-Dieter Volk, and Jens Schneider-Mergener. "Mapping of the interleukin-10/interleukin-10 receptor combining site." Protein Science 7, no. 4 (April 1998): 951–60. http://dx.doi.org/10.1002/pro.5560070412.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Shah, Neil, Jochen Kammermeier, Mamoun Elawad, and Erik-Oliver Glocker. "Interleukin-10 and Interleukin-10–Receptor Defects in Inflammatory Bowel Disease." Current Allergy and Asthma Reports 12, no. 5 (August 14, 2012): 373–79. http://dx.doi.org/10.1007/s11882-012-0286-z.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Mittal, Sharad K., Kyung-Jin Cho, Satoshi Ishido, and Paul A. Roche. "Interleukin 10 (IL-10)-mediated Immunosuppression." Journal of Biological Chemistry 290, no. 45 (September 25, 2015): 27158–67. http://dx.doi.org/10.1074/jbc.m115.682708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Holland, Gina, and Albert Zlotnik. "Interleukin-10 and Cancer." Cancer Investigation 11, no. 6 (January 1993): 751–58. http://dx.doi.org/10.3109/07357909309046950.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Kato, Masato. "Interleukin-10 and Surgery." Critical Care Medicine 29, no. 5 (May 2001): 1093. http://dx.doi.org/10.1097/00003246-200105000-00054.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Cohen, Stacey L., Aideen M. Moore, and Wendy E. Ward. "Interleukin-10 Knockout Mouse:." Inflammatory Bowel Diseases 10, no. 5 (September 2004): 557–63. http://dx.doi.org/10.1097/00054725-200409000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Rennick, Donna, Dan Berg, and Gina Holland. "Interleukin 10: An overview." Progress in Growth Factor Research 4, no. 3 (January 1992): 207–27. http://dx.doi.org/10.1016/0955-2235(92)90020-i.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Elson, C. O. "Interleukin-10 and counting …" Gastroenterology 100, no. 6 (June 1991): 1778. http://dx.doi.org/10.1016/0016-5085(91)90687-g.

Full text
APA, Harvard, Vancouver, ISO, and other styles
18

Sabat, Robert, Gerald Grütz, Katarzyna Warszawska, Stefan Kirsch, Ellen Witte, Kerstin Wolk, and Jens Geginat. "Biology of interleukin-10." Cytokine & Growth Factor Reviews 21, no. 5 (October 2010): 331–44. http://dx.doi.org/10.1016/j.cytogfr.2010.09.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Brennan, F. "Interleukin 10 and arthritis." Rheumatology 38, no. 4 (April 1, 1999): 293–97. http://dx.doi.org/10.1093/rheumatology/38.4.293.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Montero, J. G. "Interleukin 10 and Sepsis." Archives of Surgery 135, no. 7 (July 1, 2000): 875–76. http://dx.doi.org/10.1001/archsurg.135.7.875.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Peng, Hui, Wei Wang, Mo Zhou, Rui Li, Hai-Feng Pan, and Dong-Qing Ye. "Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus." Clinical Rheumatology 32, no. 9 (May 25, 2013): 1255–66. http://dx.doi.org/10.1007/s10067-013-2294-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Peng, Chih-Wen, Hao-Jen Hsu, Chun-Chun Chang, Cheng-Der Liu, Sheng-Feng Pan, and Wei-Han Huang. "Targeting of interleukin-10 receptor by a potential human interleukin-10 peptide efficiently blocks interleukin-10 pathway-dependent cell proliferation." Tzu Chi Medical Journal 32, no. 3 (2020): 245. http://dx.doi.org/10.4103/tcmj.tcmj_237_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Wang, P., P. Wu, JC Anthes, MI Siegel, RW Egan, and MM Billah. "Interleukin-10 inhibits interleukin-8 production in human neutrophils." Blood 83, no. 9 (May 1, 1994): 2678–83. http://dx.doi.org/10.1182/blood.v83.9.2678.2678.

Full text
Abstract:
Abstract In highly purified human polymorphonuclear leukocyte (PMN) preparations containing less than 0.1% contaminating monocytes, significant amounts of interleukin-8 (IL-8) and small amounts of IL-1 alpha, IL-1 beta, and tumor necrosis factor-alpha (TNF-alpha) were produced by lipopolysaccharide (LPS) stimulation. Contrary to published reports, IL- 6 production could not be detected. IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-8, and TNF-alpha in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes. Subsequent investigation of cytokine synthesis inhibitory effect of IL-10 on PMNs was focused on IL-8. IL-10 inhibited IL-8 synthesis in a dose-dependent manner and, in this regard, it was more potent than IL-4 and transforming growth factor-beta 1 (TGF-B1). In both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10. Furthermore, as determined by nuclear run-on assays, IL-10 inhibited LPS-induced transcription of IL-8 gene in MNCs. However, in PMNs, run-on assays could not reliably detect IL-8 gene transcription. These results provide the first evidence that the human peripheral neutrophil is a target for inhibition of cytokine synthesis by IL-10, and that IL-10 acts by affecting both gene transcription and mRNA stability.
APA, Harvard, Vancouver, ISO, and other styles
24

Wang, P., P. Wu, JC Anthes, MI Siegel, RW Egan, and MM Billah. "Interleukin-10 inhibits interleukin-8 production in human neutrophils." Blood 83, no. 9 (May 1, 1994): 2678–83. http://dx.doi.org/10.1182/blood.v83.9.2678.bloodjournal8392678.

Full text
Abstract:
In highly purified human polymorphonuclear leukocyte (PMN) preparations containing less than 0.1% contaminating monocytes, significant amounts of interleukin-8 (IL-8) and small amounts of IL-1 alpha, IL-1 beta, and tumor necrosis factor-alpha (TNF-alpha) were produced by lipopolysaccharide (LPS) stimulation. Contrary to published reports, IL- 6 production could not be detected. IL-10 inhibited the production of IL-1 alpha, IL-1 beta, IL-8, and TNF-alpha in LPS-stimulated PMNs, as it did in human blood mononuclear cell (MNC) preparations enriched in monocytes. Subsequent investigation of cytokine synthesis inhibitory effect of IL-10 on PMNs was focused on IL-8. IL-10 inhibited IL-8 synthesis in a dose-dependent manner and, in this regard, it was more potent than IL-4 and transforming growth factor-beta 1 (TGF-B1). In both MNCs and PMNs, degradation of LPS-induced IL-8 mRNA was enhanced by IL-10. Furthermore, as determined by nuclear run-on assays, IL-10 inhibited LPS-induced transcription of IL-8 gene in MNCs. However, in PMNs, run-on assays could not reliably detect IL-8 gene transcription. These results provide the first evidence that the human peripheral neutrophil is a target for inhibition of cytokine synthesis by IL-10, and that IL-10 acts by affecting both gene transcription and mRNA stability.
APA, Harvard, Vancouver, ISO, and other styles
25

Rentzos, M., C. Nikolaou, E. Andreadou, G. P. Paraskevas, A. Rombos, M. Zoga, A. Tsoutsou, F. Boufidou, E. Kapaki, and D. Vassilopoulos. "Circulating interleukin-10 and interleukin-12 in Parkinson’s disease." Acta Neurologica Scandinavica 119, no. 5 (May 2009): 332–37. http://dx.doi.org/10.1111/j.1600-0404.2008.01103.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Iwasaki, Yasuo, Shigeji Baba, and Ken Ikeda. "Interleukin 4 and Interleukin 10 in Creutzfeldt-Jakob Disease." Archives of Neurology 63, no. 6 (June 1, 2006): 911. http://dx.doi.org/10.1001/archneur.63.6.911-a.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Ammirati, Enrico, Carlo V. Cannistraci, Nicole A. Cristell, Viviana Vecchio, Alessio G. Palini, Per Tornvall, Anna M. Paganoni, et al. "Identification and Predictive Value of Interleukin-6 + Interleukin-10 + and Interleukin-6 − Interleukin-10 + Cytokine Patterns in ST-Elevation Acute Myocardial Infarction." Circulation Research 111, no. 10 (October 26, 2012): 1336–48. http://dx.doi.org/10.1161/circresaha.111.262477.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Freer, Giulia. "Interleukin 10 in Antiviral Responses." Current Immunology Reviews 12, no. 1 (March 30, 2016): 20–26. http://dx.doi.org/10.2174/1573395512666151216210559.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Benjamin, David, Chanun D. Park, and Venkatanarayanan Sharma. "Human B Cell Interleukin 10." Leukemia & Lymphoma 12, no. 3-4 (January 1994): 205–9. http://dx.doi.org/10.3109/10428199409059591.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Cihakova, Daniela. "Interleukin-10 stiffens the heart." Journal of Experimental Medicine 215, no. 2 (January 18, 2018): 379–81. http://dx.doi.org/10.1084/jem.20180049.

Full text
Abstract:
Cardiac-resident macrophages are a diverse population of cells that have a critical role in the pathogenesis of heart failure. A new understanding of communication between macrophages and cardiac fibroblasts could lead to novel therapeutic strategies for heart failure with preserved ejection function.
APA, Harvard, Vancouver, ISO, and other styles
31

SCHREIBER, STEFAN. "Interleukin-10 in the intestine." Gut 41, no. 2 (August 1, 1997): 274–75. http://dx.doi.org/10.1136/gut.41.2.274.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Garofalo, Roberto, Sadhana Chheda, Fang Mei, Kimberly H. Palkowetz, Helen E. Rudloff, Frank C. Schmalstieg, David K. Rassin, and Armond S. Goldman. "Interleukin-10 in Human Milk." Pediatric Research 37, no. 4 (April 1995): 444–49. http://dx.doi.org/10.1203/00006450-199504000-00010.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Bogdan, C., Y. Vodovotz, and C. Nathan. "Macrophage deactivation by interleukin 10." Journal of Experimental Medicine 174, no. 6 (December 1, 1991): 1549–55. http://dx.doi.org/10.1084/jem.174.6.1549.

Full text
Abstract:
Recombinant mouse interleukin 10 (IL-10) was exceedingly potent at suppressing the ability of mouse peritoneal macrophages (m phi) to release tumor necrosis factor alpha (TNF-alpha). The IC50 of IL-10 for the suppression of TNF-alpha release induced by 0.5 microgram/ml lipopolysaccharide was 0.04 +/- 0.03 U/ml, with as little as 1 U/ml suppressing TNF-alpha production by a factor of 21.4 +/- 2.5. At 10 U/ml, IL-10 markedly suppressed m phi release of reactive oxygen intermediates (ROI) (IC50 3.7 +/- 1.8 U/ml), but only weakly inhibited m phi release of reactive nitrogen intermediates (RNI). Since TNF-alpha is a T cell growth and differentiation factor, whereas ROI and RNI are known to inhibit lymphocyte function, it is possible that m phi exposed to low concentrations of IL-10 suppress lymphocytes. m phi deactivated by higher concentrations of IL-10 might be permissive for the growth of microbial pathogens and tumor cells, as TNF-alpha, ROI, and RNI are major antimicrobial and tumoricidal products of m phi. IL-10's effects on m phi overlap with but are distinct from the effects of the two previously described cytokines that suppress the function of mouse m phi, transforming growth factor beta and macrophage deactivation factor. Based on results with neutralizing antibodies, all three m phi suppressor factors appear to act independently.
APA, Harvard, Vancouver, ISO, and other styles
34

Marchant, A., M. Goldman, J. Devière, B. Byl, J. L. Vincent, and D. De Groote. "Interleukin-10 production during septicaemia." Lancet 343, no. 8899 (March 1994): 707–8. http://dx.doi.org/10.1016/s0140-6736(94)91584-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Moore, Kevin W., Rene de Waal Malefyt, Robert L. Coffman, and Anne O'Garra. "INTERLEUKIN-10AND THEINTERLEUKIN-10 RECEPTOR." Annual Review of Immunology 19, no. 1 (April 2001): 683–765. http://dx.doi.org/10.1146/annurev.immunol.19.1.683.

Full text
APA, Harvard, Vancouver, ISO, and other styles
36

Howard, Maureen, Anne O'Garra, Hiroshi Ishida, René de Waal Malefyt, and Jan De Vries. "Biological properties of interleukin 10." Journal of Clinical Immunology 12, no. 4 (July 1992): 239–47. http://dx.doi.org/10.1007/bf00918147.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Howard, Maureen, and Anne O'Garra. "Biological properties of interleukin 10." Immunology Today 13, no. 6 (January 1992): 198–200. http://dx.doi.org/10.1016/0167-5699(92)90153-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Asadullah, Khusru, Wolf-Dietrich Döcke, Robert Sabat, Merle Ebeling, Hans-Dieter Volk, and Wolfram Sterry. "Interleukin-10 in der Dermatologie." Der Hautarzt 50, no. 1 (January 22, 1999): 12–19. http://dx.doi.org/10.1007/s001050050858.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Wande, I. Nyoman, Endang Retnowati, and Juli Soemarsono. "KADAR INTERLEUKIN 10 (IL-10) MALARIA DAN ANEMIA." INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY 18, no. 1 (October 14, 2016): 4. http://dx.doi.org/10.24293/ijcpml.v18i1.767.

Full text
Abstract:
Anaemia is an important complication of malaria, and its pathogenesis is not well understood. High level of the Th2 cytokine (such as IL-10), which counteract the Th1 cytokine, might prevent the development of severe malarial anaemia. The purpose of this study was to know the comparation between the plasma level of IL-10 in malaria patients with anaemia and without anaemia. The plasma level of IL-10 was examined in 16 malaria patients with anaemia and 16 malaria caused by P. falciparum patients without anaemia samplestaken from patients at the primary health centres in West Lombok and Centre Lombok during March until July 2008. The samples were measured using ELISA. The concentration of haemoglobin (Hb) was measured using hematological analyzer. The anaemia concentration of Hb is <11 g/dL. The results were analyzed using two (2) sample t test with SPSS ver.13.The plasma level of IL-10 in malaria patients caused by P. falciparum with anaemia was 8.81(3.04) [mean(SD)] pg/mL where as the plasma level of IL-10 in malaria patients without anaemia was 47.99(25.26) pg/mL. The mean of IL-10 level in malaria falciparum patients with anaemia was significantly lower than that of malaria patients caused by P. falciparum without anaemia (p=0.000).
APA, Harvard, Vancouver, ISO, and other styles
40

Furukawa, Yutaka, Gerold Becker, Jennifer L. Stinn, Koichi Shimizu, Peter Libby, and Richard N. Mitchell. "Interleukin-10 (IL-10) Augments Allograft Arterial Disease." American Journal of Pathology 155, no. 6 (December 1999): 1929–39. http://dx.doi.org/10.1016/s0002-9440(10)65512-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Salwen, S. A., T. Sato, K. Masuoka, G. Inoue, M. J. Mastrangelo, and D. Berd. "INTERLEUKIN-10 (IL-10) PRODUCTION BY MELANOMA CELLS." Journal of Immunotherapy 18, no. 2 (August 1995): 129. http://dx.doi.org/10.1097/00002371-199508000-00014.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

BENDTZEN, KLAUS, MORTEN B. HANSEN, MARCUS DIAMANT, CHRISTIAN ROSS, and MORTEN SVENSON. "Naturally Occurring Autoantibodies to Interleukin-1α, Interleukin-6, Interleukin-10, and Interferon-α." Journal of Interferon Research 14, no. 4 (August 1994): 157–58. http://dx.doi.org/10.1089/jir.1994.14.157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Diller, R., D. Palmes, K. H. Dietl, N. Senninger, G. Winde, and H. U. Spiegel. "Interleukin-6, interleukin-8, and interleukin-10 in kidney transplantation: improved risk strategy?" Transplantation Proceedings 35, no. 4 (June 2003): 1333–37. http://dx.doi.org/10.1016/s0041-1345(03)00529-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Tilg, Herbert, Michael B. Atkins, Charles A. Dinarello, and James W. Mier. "Induction of circulating interleukin 10 by interleukin 1 and interleukin 2, but not interleukin 6 immunotherapy." Cytokine 7, no. 7 (October 1995): 734–39. http://dx.doi.org/10.1006/cyto.1995.0087.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

MIOSSEC, PIERRE, and Pierre Miossec. "Interleukin-4 and Interleukin-10 as Antagonists of Interferon-γ." Journal of Interferon Research 14, no. 5 (October 1994): 285. http://dx.doi.org/10.1089/jir.1994.14.285.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Glynn, P., R. Coakley, I. Kilgallen, N. Murphy, and S. O'Neill. "Circulating interleukin 6 and interleukin 10 in community acquired pneumonia." Thorax 54, no. 1 (January 1, 1999): 51–55. http://dx.doi.org/10.1136/thx.54.1.51.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Kovarik, Johannes J., Elisabeth Kernbauer, Markus A. Hölzl, Johannes Hofer, Guido A. Gualdoni, Klaus G. Schmetterer, Fitore Miftari, et al. "Fasting metabolism modulates the interleukin-12/interleukin-10 cytokine axis." PLOS ONE 12, no. 7 (July 24, 2017): e0180900. http://dx.doi.org/10.1371/journal.pone.0180900.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Wolk, K., E. Witte, U. Reineke, K. Witte, M. Friedrich, W. Sterry, K. Asadullah, H.-D. Volk, and R. Sabat. "Is there an interaction between interleukin-10 and interleukin-22?" Genes & Immunity 6, no. 1 (November 4, 2004): 8–18. http://dx.doi.org/10.1038/sj.gene.6364144.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Denison, F. C. "Seminal plasma components stimulate interleukin-8 and interleukin-10 release." Molecular Human Reproduction 5, no. 3 (March 1, 1999): 220–26. http://dx.doi.org/10.1093/molehr/5.3.220.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

El-Shabrawi, Y. "Interleukin-12 und Interleukin-10 in intraokulären Flüssigkeiten von Uveitispatienten." Spektrum der Augenheilkunde 13, no. 1 (February 1999): 1–5. http://dx.doi.org/10.1007/bf03162708.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Interleukin 10' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography